APLT Applied Therapeutics Inc

Price (delayed)

$14.26

Market cap

$373.3M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.38

Enterprise value

$296.4M

Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company's lead drug candidate, ...

Highlights
APLT's debt is down by 17% year-on-year and by 6% since the previous quarter
The company's net income has shrunk by 51% YoY but it rose by 2.1% QoQ
The company's EPS fell by 8% YoY but it rose by 6% QoQ
The quick ratio has declined by 28% since the previous quarter and by 27% year-on-year
The equity has declined by 17% since the previous quarter and by 14% year-on-year

Key stats

What are the main financial stats of APLT
Market
Shares outstanding
26.18M
Market cap
$373.3M
Enterprise value
$296.4M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.31
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$103.04M
EBITDA
-$102.64M
Free cash flow
-$91.56M
Per share
EPS
-$4.38
Free cash flow per share
-$3.51
Book value per share
$4.31
Revenue per share
$0
TBVPS
$5.25
Balance sheet
Total assets
$136.96M
Total liabilities
$24.52M
Debt
$1.54M
Equity
$112.44M
Working capital
$111.85M
Liquidity
Debt to equity
0.01
Current ratio
5.78
Quick ratio
5.37
Net debt/EBITDA
0.75
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-79.3%
Return on equity
-95.8%
Return on invested capital
-234.6%
Return on capital employed
-90.7%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

APLT stock price

How has the Applied Therapeutics stock price performed over time
Intraday
-0.7%
1 week
-3.65%
1 month
-12.52%
1 year
-40.46%
YTD
-35.21%
QTD
-31.38%

Financial performance

How have Applied Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$103.79M
Net income
-$103.54M
Gross margin
N/A
Net margin
N/A
The company's net income has shrunk by 51% YoY but it rose by 2.1% QoQ
Applied Therapeutics's operating income has plunged by 50% YoY but it has increased by 2.3% from the previous quarter

Growth

What is Applied Therapeutics's growth rate over time

Valuation

What is Applied Therapeutics stock price valuation
P/E
N/A
P/B
3.31
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS fell by 8% YoY but it rose by 6% QoQ
APLT's price to book (P/B) is 30% less than its last 4 quarters average of 4.7
The equity has declined by 17% since the previous quarter and by 14% year-on-year

Efficiency

How efficient is Applied Therapeutics business performance
The return on equity has declined by 22% year-on-year
APLT's return on invested capital is down by 16% year-on-year but it is up by 4.3% since the previous quarter
The return on assets has declined by 16% year-on-year

Dividends

What is APLT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for APLT.

Financial health

How did Applied Therapeutics financials performed over time
The quick ratio has declined by 28% since the previous quarter and by 27% year-on-year
The current ratio has contracted by 27% YoY and by 26% from the previous quarter
APLT's debt is 99% smaller than its equity
The equity has declined by 17% since the previous quarter and by 14% year-on-year
APLT's debt is down by 17% year-on-year and by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.